HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis.

Abstract
Angiogenesis is critical in the progression of prostate cancer. However, the interplay between the proliferation kinetics of tumor endothelial cells (angiogenesis) and tumor cells has not been investigated. Also, protein kinase C (PKC) regulates various aspects of tumor cell growth, but its role in prostate cancer has not been investigated in detail. Here, we found that the proliferation rates of endothelial and tumor cells oscillate asynchronously during the growth of human prostate cancer xenografts. Furthermore, our analyses suggest that PKCbetaII was activated during increased angiogenesis and that PKCbetaII plays a key role in the proliferation of endothelial cells and tumor cells in human prostate cancer; treatment with a PKCbetaII-selective inhibitor, betaIIV5-3, reduced angiogenesis and tumor cell proliferation. We also find a unique effect of PKCbetaII inhibition on normalizing pericentrin (a protein regulating cytokinesis), especially in endothelial cells as well as in tumor cells. PKCbetaII inhibition reduced the level and mislocalization of pericentrin and normalized microtubule organization in the tumor endothelial cells. Although pericentrin has been known to be up-regulated in epithelial cells of prostate cancers, its level in tumor endothelium has not been studied in detail. We found that pericentrin is up-regulated in human tumor endothelium compared with endothelium adjacent to normal glands in tissues from prostate cancer patients. Our results suggest that a PKCbetaII inhibitor such as betaIIV5-3 may be used to reduce prostate cancer growth by targeting both angiogenesis and tumor cell growth.
AuthorsJeewon Kim, Yoon-La Choi, Alice Vallentin, Ben S Hunrichs, Marc K Hellerstein, Donna M Peehl, Daria Mochly-Rosen
JournalCancer research (Cancer Res) Vol. 68 Issue 16 Pg. 6831-9 (Aug 15 2008) ISSN: 1538-7445 [Electronic] United States
PMID18701509 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Antigens
  • Microtubule-Associated Proteins
  • Peptide Fragments
  • Protein Kinase Inhibitors
  • pericentrin
  • Protein Kinase C
  • Protein Kinase C beta
Topics
  • Adenocarcinoma (blood supply, metabolism, pathology)
  • Animals
  • Antigens (metabolism)
  • Blotting, Western
  • Cell Proliferation
  • Centrosome (enzymology)
  • Epithelial Cells (metabolism, pathology)
  • Fluorescent Antibody Technique
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Immunoenzyme Techniques
  • Immunoprecipitation
  • Male
  • Mice
  • Mice, Nude
  • Microtubule-Associated Proteins (metabolism)
  • Neovascularization, Pathologic
  • Peptide Fragments (administration & dosage, chemical synthesis)
  • Prostate (metabolism, pathology)
  • Prostatic Hyperplasia (metabolism, pathology)
  • Prostatic Neoplasms (blood supply, metabolism, pathology)
  • Protein Kinase C (metabolism)
  • Protein Kinase C beta
  • Protein Kinase Inhibitors (pharmacology)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: